Page 1 of 1

Merck fined AUD$75,000 for Movectro advertising

Posted: Tue Apr 19, 2011 2:55 am
by hwebb
Merck Serono, makers of leukemia drug Cladribine (now marketed as MS drug Movectro) have been fined A$75,000 for breach of the Medicines Australia Code of Conduct for their Movectro advertisement on the Australian Channel 7 news last year. The advertisement was presented as a news item, and was performed by neurologist Dr Bill Carroll (Multiple Sclerosis Research Australia) and MS Australia.

In Australia, it is not legal to advertise a prescription medication direct to the consumer.

I’m sure Merck Serono still view this as cheap advertising.